Provectus Pharmaceuticals provectusbio.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1132)

Provectus Pharmaceuticals (OTCQB: PVCT) is a clinical-stage biopharmaceutical company developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. Provectus' investigational oncology drug, PV-10, is an oncolytic immunotherapy currently enrolling patients in Phase 3 clinical trials for metastatic melanoma. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug...Show all

Provectus Pharmaceuticals (OTCQB: PVCT) is a clinical-stage biopharmaceutical company developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. Provectus' investigational oncology drug, PV-10, is an oncolytic immuno...Show all

Company (Alive / Active)

Phone: 866-594-5999

Fax:

7327 Oak Ridge Highway

Knoxville, 37931
Tennessee, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Provectus Pharmaceuticals $1.8M Nov 4, 2010

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Provectus Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.